Posted in | News | Medical Optics

MRI Interventions’ ClearPoint Neuro Intervention System Featured on TV

The ClearPoint® Neuro Intervention System developed by MRI Interventions, Inc. was featured December 10 in a television segment and article reported by the ABC-TV affiliate in Boston (WCVB-TV).

The report, filmed in part at Brigham and Women's Hospital in Boston, highlighted how the ClearPoint System enables neurosurgeons to view the inside of patients' brains in real time while they operate, using intraoperative MRI imaging. The report—which spotlights one female patient whose tremor was alleviated following a ClearPoint-guided surgery—notes that the technology is being used in surgical procedures to treat epilepsy, pediatric dystonia and Parkinson's disease, and is being used in clinical trials to deliver investigational drugs for conditions such as brain cancer.

To watch the television segment and read the accompanying article, please visit the following link:

http://www.wcvb.com/health/new-brain-surgery-technology-giving-hope-to-patients/-/9848730/23419416/-/uwigknz/-/index.html

About the ClearPoint System

The ClearPoint® Neuro Intervention System is a navigation platform designed to allow real-time, direct visualization during minimally-invasive neurosurgical procedures. ClearPoint software works with MRI to assist surgeons in planning a target and trajectory, and the SmartFrame® targeting device enables the MRI-guided alignment and insertion of surgical instruments. The ClearPoint System has been used to enable asleep deep brain stimulation procedures, laser ablation therapy and brain biopsy, and is currently involved in five clinical trials investigating direct drug delivery in the brain.

The ClearPoint SmartFlow® cannula is presently FDA-cleared for injection of cytarabine, a chemotherapy drug, to the ventricles or removal of CSF from the ventricles during intracranial procedures. Delivery of other therapeutic agents using the SmartFlow cannula is investigational.

About MRI Interventions, Inc.

Founded in 1998, MRI Interventions is creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain and heart. Utilizing a hospital's existing MRI suite, the company's FDA-cleared and CE-marked ClearPoint System is designed to enable a range of minimally invasive procedures in the brain. MRI Interventions has a co-development and co-distribution agreement with Brainlab, a leader in software-driven medical technology, relating to the ClearPoint system. In partnership with Siemens Healthcare, MRI Interventions is developing the ClearTrace® System to enable MRI-guided catheter ablations to treat cardiac arrhythmias, including atrial fibrillation. Building on the imaging power of MRI, the company's interventional platforms strive to improve patient care while reducing procedure costs and times. MRI Interventions is also working with Boston Scientific Corporation to incorporate its MRI-safety technologies into Boston Scientific's implantable leads for cardiac and neurological applications.

Source: http://www.mriinterventions.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit